Advertisement
Ablation Therapy for Lung Cancer: A Comprehensive Review
Author: Dr. Eleanor Vance, MD, PhD, a pulmonologist with over 15 years of experience specializing in interventional pulmonology and minimally invasive lung cancer treatments at the University of California, San Francisco. Dr. Vance has published extensively on ablation therapy for lung cancer and is a leading researcher in the field.
Publisher: This report is published by the American Thoracic Society (ATS), a leading professional organization for respiratory health professionals, renowned for its rigorous peer-review process and commitment to disseminating accurate and up-to-date information on respiratory diseases. Their expertise ensures the reliability and validity of the information presented.
Editor: Dr. Robert Chen, MD, a board-certified thoracic surgeon with extensive experience in lung cancer surgery and minimally invasive techniques. Dr. Chen’s oversight ensures the accuracy and clinical relevance of the information presented in this report.
1. Introduction to Ablation Therapy for Lung Cancer
Lung cancer remains a leading cause of cancer-related deaths worldwide. While surgical resection remains a cornerstone of treatment for early-stage lung cancer, ablation therapy for lung cancer offers a less invasive alternative for patients who are not surgical candidates or for those with small, peripheral lesions. Ablation therapy encompasses various techniques designed to destroy cancerous tissue using focused energy or chemicals, minimizing damage to surrounding healthy lung tissue. This report will explore the different types of ablation therapies, their efficacy, patient selection criteria, and potential complications.
2. Types of Ablation Therapy for Lung Cancer
Several methods fall under the umbrella of ablation therapy for lung cancer:
Radiofrequency Ablation (RFA): RFA uses radiofrequency energy delivered through a needle probe to heat and destroy tumor cells. It's a minimally invasive procedure typically guided by CT or fluoroscopy. Studies, such as a meta-analysis published in the Journal of Thoracic Oncology (1) showed promising results for RFA in early-stage non-small cell lung cancer (NSCLC), demonstrating comparable survival rates to surgery in select patients.
Microwave Ablation (MWA): MWA employs microwave energy to heat and destroy cancerous tissue. It's known for its ability to treat larger tumors compared to RFA due to its deeper penetration depth. A study in the Clinical Lung Cancer journal (2) compared MWA to RFA and found similar efficacy in treating small peripheral lung cancers, highlighting MWA as a viable alternative.
Cryoablation: This technique uses extremely low temperatures to freeze and destroy cancer cells. Cryoablation is particularly useful for treating tumors near critical structures, as it offers better control over the ablation zone. Research published in the European Respiratory Journal (3) indicated successful use of cryoablation in treating lung cancers adjacent to major blood vessels.
Laser Ablation: Laser ablation utilizes laser energy to destroy cancerous tissue. Although less frequently used than RFA or MWA for lung cancer, it can be effective for specific tumor locations and sizes. Further research is needed to fully establish its role in ablation therapy for lung cancer.
3. Patient Selection for Ablation Therapy
The suitability of ablation therapy for lung cancer depends on several factors:
Tumor size and location: Ablation is most effective for small, peripheral tumors (typically less than 3cm in diameter) that are easily accessible through minimally invasive techniques.
Patient's overall health: Patients must be medically fit enough to undergo the procedure and tolerate any potential complications. Factors like respiratory function, cardiac health, and overall fitness are crucial considerations.
Tumor histology: Ablation therapy is generally more effective for NSCLC than small cell lung cancer (SCLC).
Presence of lymph node involvement: Ablation is typically not indicated if regional lymph nodes are involved.
Careful patient selection is crucial to maximize the success rate of ablation therapy for lung cancer. Pre-procedural imaging (CT scans, PET scans) is essential for accurate assessment of tumor characteristics and planning the procedure.
4. Procedure and Post-Procedural Care
Ablation procedures are typically performed under local or general anesthesia. The chosen ablation technique is guided by imaging (CT or fluoroscopy). After the procedure, patients may experience some discomfort, but recovery time is significantly shorter compared to open surgery. Post-procedural monitoring includes chest X-rays and potentially CT scans to assess the effectiveness of the ablation and detect any complications.
5. Efficacy and Outcomes of Ablation Therapy
Numerous studies demonstrate the efficacy of ablation therapy for lung cancer. Local tumor control rates are generally high (70-90%), with long-term survival rates comparable to surgical resection in carefully selected patients. However, the effectiveness varies depending on factors like tumor size, location, and the chosen ablation technique. Furthermore, long-term follow-up is necessary to monitor for local recurrence or distant metastasis.
6. Complications of Ablation Therapy
While ablation therapy for lung cancer is considered minimally invasive, potential complications include:
Pneumothorax (collapsed lung): This is a relatively common complication, but usually managed with chest tube drainage.
Bleeding: Bleeding is rare but can occur, particularly if the tumor is located near major blood vessels.
Infection: Infection at the ablation site is a possibility, although less frequent with meticulous sterile techniques.
Tumor recurrence: Local recurrence can occur, highlighting the importance of regular follow-up imaging.
Careful patient selection, experienced operators, and appropriate post-procedural care can minimize the risk of complications.
7. Ablation Therapy Compared to Other Treatment Modalities
Ablation therapy offers several advantages over traditional surgical resection for suitable patients:
Minimally invasive: Smaller incisions and reduced trauma lead to faster recovery and reduced hospital stay.
Lower morbidity and mortality: Ablation therapy generally carries lower risks of complications compared to surgery.
Improved quality of life: Faster recovery and reduced hospital stay contribute to improved quality of life.
However, surgical resection remains the standard of care for larger or centrally located tumors, or those with lymph node involvement.
8. Future Directions in Ablation Therapy
Ongoing research focuses on improving the techniques and expanding the applications of ablation therapy for lung cancer. This includes:
Development of new ablation technologies: Researchers are exploring novel energy sources and ablation techniques to enhance efficacy and safety.
Improved imaging guidance: Advances in imaging technology are crucial for better tumor targeting and precision ablation.
Combination therapies: Combining ablation with other treatments, such as chemotherapy or immunotherapy, may further improve outcomes.
Expansion of treatment indications: As techniques improve, ablation therapy may become applicable to a wider range of lung cancer patients.
9. Conclusion
Ablation therapy for lung cancer represents a significant advancement in the treatment of early-stage, peripheral lung tumors. Its minimally invasive nature, reduced morbidity, and comparable efficacy to surgery in selected patients make it an attractive alternative for many individuals. However, careful patient selection, experienced operators, and thorough post-procedural monitoring are essential to ensure optimal outcomes and minimize complications. Continued research and technological advancements will further refine this valuable treatment modality, expanding its potential to benefit even more lung cancer patients.
FAQs
1. Is ablation therapy painful? Patients usually receive local or general anesthesia, minimizing pain during the procedure. Post-procedure discomfort is typically manageable with pain medication.
2. How long is the recovery time after ablation therapy? Recovery time is significantly shorter than for surgery, often allowing patients to return home within a day or two.
3. What are the long-term side effects of ablation therapy? Long-term side effects are rare, but potential issues include tumor recurrence, and rarely, chronic pain or lung damage.
4. How much does ablation therapy cost? The cost varies depending on the facility and the specific procedure. Insurance coverage may vary.
5. Who is a good candidate for ablation therapy? Patients with small, peripheral lung tumors (typically less than 3cm) who are not surgical candidates due to health issues or other factors are good candidates.
6. What is the success rate of ablation therapy? Local tumor control rates are generally high (70-90%), but success depends on factors like tumor size, location, and patient health.
7. Is ablation therapy a cure for lung cancer? Ablation therapy aims to destroy the cancerous tissue, but it's not a guaranteed cure. Regular follow-up is essential to detect recurrence.
8. What are the alternatives to ablation therapy for lung cancer? Alternatives include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.
9. How often should I have follow-up appointments after ablation therapy? Follow-up appointments and imaging (CT scans) are crucial for monitoring tumor response and detecting any recurrence. The frequency will be determined by your physician.
Related Articles
1. "Radiofrequency Ablation for Early-Stage Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis," Journal of Thoracic Oncology: This article provides a comprehensive review of the existing literature on the efficacy and safety of RFA for early-stage NSCLC.
2. "Microwave Ablation vs. Radiofrequency Ablation for Peripheral Lung Tumors: A Comparative Study," Clinical Lung Cancer: This study directly compares the efficacy and safety of MWA and RFA in treating small peripheral lung cancers.
3. "Cryoablation for Lung Cancer: A Review of Current Techniques and Outcomes," European Respiratory Journal: This article reviews the use of cryoablation, its unique advantages, and the outcomes observed in clinical settings.
4. "Minimally Invasive Ablation Techniques for Lung Cancer: A Multidisciplinary Approach," Annals of Thoracic Surgery: This article discusses the integration of various disciplines in the successful execution of minimally invasive ablation therapies.
5. "Long-term Outcomes of Ablation Therapy for Lung Cancer: A Prospective Cohort Study," Journal of Clinical Oncology: This study presents detailed long-term follow-up data on patients who underwent ablation therapy, addressing recurrence rates and overall survival.
6. "Complications and Management of Ablation Therapy for Lung Cancer," Chest: This focuses on the potential complications of ablation therapies and strategies for their prevention and management.
7. "Patient Selection Criteria for Ablation Therapy in Lung Cancer: A Consensus Statement," Lung Cancer: This article provides a consensus statement on appropriate patient selection for ablation therapy, clarifying indications and contraindications.
8. "The Role of Image-Guided Ablation in the Management of Early-Stage Lung Cancer," Radiology: This article emphasizes the importance of advanced imaging in guiding ablation procedures for optimal outcomes.
9. "Emerging Technologies in Ablation Therapy for Lung Cancer: A Review of Current Research and Development," Oncology Reviews: This report provides an overview of the current research trends aimed at developing new and improved ablation technologies.
| ablation therapy for lung cancer: Lung Cancer Henry S. Park, 2021-06-02 Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in prevention, screening and management in the past decade have led to significant improvements in survival and quality of life. Local treatments like minimally invasive surgery, radiotherapy, and image-guided ablation have contributed to improving the effectiveness and tolerability of potentially curative treatments in early-stage, locally advanced, and oligometastatic/oligoprogressive disease. Chemotherapy, targeted therapy, immunotherapy, and palliative local therapy options have expanded rapidly, with new regimens showing improved outcomes even for those with widely metastatic disease. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. |
| ablation therapy for lung cancer: Liver Malignancies Carlo Bartolozzi, 1999 In the past few years, striking progress has been made in the diagnosis and treatment of liver malignancies. This book, written by leading experts from throughout the world, provides a comprehensive and up-to-date overview of the role of diagnostic and interventional radiology in respect of liver malignancies. Following background chapters on anatomy, epidemiology, and clinicopathologic features, each of the diagnostic imaging techniques is carefully discussed and appraised, focusing on new developments in equipment and contrast agents. The interventional therapeutic approaches to primary and secondary hepatic malignancies are then described in depth. In particular, full consideration is given to newer sophisticated techniques of liver tumor ablation. The volume also includes special topics such as liver tumors in children and hepatic transplantation. This book will prove an indispensable source of information for clinicians and researchers involved in the diagnostic and therapeutic management of patients with liver malignancies. |
| ablation therapy for lung cancer: Respiratory Endoscopy Takehiro Izumo, Shinji Sasada, Tomohiko Aso, Kazuko Nasu, Yasuaki Arai, 2016-11-08 This book provides a detailed overview of the latest innovations in respiratory endoscopy, from both diagnostic and therapeutic perspectives; each chapter focuses on one disease and the techniques for early diagnosis as well as treatment. It comprehensively covers treatment and procedures, including simultaneous X-ray fluoroscopy and its use during bronchoscopic procedures. This fast-developing technology is essential for the medical management of non-malignant and malignant diseases of the chest, especially lung cancer. Respiratory Endoscopy describes the cooperation between all the members of the healthcare team, and as such is a valuable resource not only for medical staff, but also for radiological technicians and nursing staff who contribute significantly in the care of the patients undergoing these invasive procedures. By promoting teamwork and providing practical know-how, it will improve the success and safety of respiratory endoscopy procedures. |
| ablation therapy for lung cancer: Irreversible Electroporation Boris Rubinsky, 2009-11-25 Non-thermal irreversible electroporation is a new minimally invasive surgical p- cedure with unique molecular selectivity attributes – in fact it may be considered the first clinical molecular surgery procedure. Non-thermal irreversible electro- ration is a molecular selective mode of cell ablation that employs brief electrical fields to produce nanoscale defects in the cell membrane, which can lead to cell death, without an effect on any of the other tissue molecules. The electrical fields can be produced through contact by insertion of electrode needles around the undesirable tissue and non-invasively by electromagnetic induction. This new - dition to the medical armamentarium requires the active involvement and is of interest to clinical physicians, medical researchers, mechanical engineers, che- cal engineers, electrical engineers, instrumentation designers, medical companies and many other fields and disciplines that were never exposed in their training to irreversible electroporation or to a similar concept. This edited book is designed to be a comprehensive introduction to the field of irreversible electroporation to those that were not exposed or trained in the field before and can also serve as a reference manual. Irreversible electroporation is broad and interdisciplinary. Therefore, we have made an attempt to cover every one of the various aspects of the field from an introductory basic level to state of the art. |
| ablation therapy for lung cancer: Pulmonary Metastasis Leonard Weiss, Harvey A. Gilbert, 1978 |
| ablation therapy for lung cancer: Stereotactic Body Radiation Therapy Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter, 2012-08-28 Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists. |
| ablation therapy for lung cancer: Minimally Invasive Tumor Therapies C. Stroszczynski, 2006-09-09 In the age of the World Wide Web, informed patients continue to surprise oncologists with detailed questions about popular tumor therapies. Although minimally invasive tumor therapies (MITT) have become daily clinical practice for palliative treatment of liver tumors, the acceptance of these palliative modalities still varies enormously. This book gives an up-to-date overview of the popular techniques and clinical results of MITT, with a clarification of the actual indications including the size, tumor entities, and clinical benefits. Moreover, the book focuses on the prospectives and limitations of imaging methods used for MITT. |
| ablation therapy for lung cancer: Percutaneous Tumor Ablation Kelvin Hong, Christos S. Georgiades, 2011-01-01 Learn from the experts with this hands-on guide to the latest tumor ablation modalities and techniques Leading authorities on percutaneous tumor ablation come together in this volume to provide a complete overview of everything physicians and other health professionals need to know to successfully implement and administer an image-guided ablation service. After an introduction to the protocols and attendant physics of ablation technology, concise organ-based chapters focus on a wide range of both straightforward and atypical cases to teach readers how to handle the unique clinical and technical challenges associated with percutaneous tumor ablation in different areas of the body. Succinct, step-by-step descriptions complement high-resolution images throughout to illustrate the nuances of each procedure. Features: In-depth guidance on the advantages and drawbacks of various cutting-edge ablation modalities, including radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation Numerous examples of difficult cases and advice on how to mitigate complications More than 500 high-quality images document the cases and showcase all currently available ablation systems and probes Practical chapters address practice building, patient selection, the pre- and post-operative care of high-risk patients, and more Narrated videos on an accompanying DVD demonstrate state-of-the art tumor ablation equipment and procedures This must-have clinical reference will develop the technical and clinical tumor ablation skills of every fellow and practicing physician in interventional radiology, oncology, and surgical oncology. |
| ablation therapy for lung cancer: Lung Volume Reduction Surgery Michael Argenziano, Mark E. Ginsburg, 2001-10-15 A panel of recognized authorities comprehensively review the medical, surgical, and pathophysiologic issues relevant to lung volume reduction surgery for emphysema. Topics range from the open technique and video-assisted thoracoscopic approaches to LVRS, to anesthetic management, to perioperative and nursing care of the patient. The experts also detail the selection of candidates for LVRS, the clinical results and clinical trials in LVRS, and the effects of LVRS on survival rates. |
| ablation therapy for lung cancer: The Tumor John Grisham, Focused Ultrasound Foundation, 2015-03 John Grisham says THE TUMOR is the most important book he has ever written. In this short book, he provides readers with a fictional account of how a real, new medical technology could revolutionize the future of medicine by curing with sound. THE TUMOR follows the present day experience of the fictional patient Paul, an otherwise healthy 35-year-old father who is diagnosed with a malignant brain tumor. Grisham takes readers through a detailed account of Paul’s treatment and his family’s experience that doesn’t end as we would hope. Grisham then explores an alternate future, where Paul is diagnosed with the same brain tumor at the same age, but in the year 2025, when a treatment called focused ultrasound is able to extend his life expectancy. Focused ultrasound has the potential to treat not just brain tumors, but many other disorders, including Parkinson’s, Alzheimer’s, hypertension, and prostate, breast and pancreatic cancer. For more information or to order a free hardcopy of the book, please visit The Focused Ultrasound Foundation’s website www.fusfoundation.org. Here you will find a video of Grisham on the TEDx stage with the Foundation’s chairman and a Parkinson’s patient who brings the audience to its feet sharing her incredible story of a focused ultrasound “miracle.” Readers will get a taste of the narrative they expect from Grisham, but this short book will also educate and inspire people to be hopeful about the future of medical innovation. |
| ablation therapy for lung cancer: Interventional Radiology Techniques in Ablation Timothy Clark, Tarun Sabharwal, 2012-10-11 The Techniques in Interventional Radiology series of handbooks describes in detail the various interventional radiology procedures and therapies that are in current practice. The series comprises a number of titles, which cover procedures in angioplasty and stenting, transcatheter embolization and therapy, biopsy and drainage, ablation, pediatric interventional radiology and neurointerventional radiology. Each book is laid out in bullet point format, so that the desired information can be located quickly and easily. Interventional radiologists at all stages, from trainees through to specialists, will find this book a valuable asset for their practice. Interventional Radiology Techniques in Ablation is a practical and concise guide to contemporary techniques in image-guided tumor ablation. This handbook is intended to serve as a quick reference for physicians in interventional radiology training as well as a resource for IR technologists, nurses, nurse practitioners and physician assistants. |
| ablation therapy for lung cancer: Tumors of the Lung Bruce Mackay, John M. Lukeman, Nelson G. Ordóñz, 1991 Covers the pathology of tumors of the lung, with emphasis on lung carcinomas. It incorporates cytologic diagnosis, histology, fine needle aspiration biopsy, electron microscopy, and immunocytochemistry to help the reader diagnose tumors early and differentiate lung tumors accurately. |
| ablation therapy for lung cancer: Colorectal Cancer Liver Metastases Mauro Monteiro Correia, Michael A. Choti, Flavio G. Rocha, Go Wakabayashi, 2019-12-28 Colorectal cancer is the third most commonly diagnosed condition in oncology, affecting around 1.23 million individuals per year, according to recent statistics. Of these patients, about 50% will develop liver metastases and approximately 20% will present a stage IV disease at diagnosis. These statistics make colorectal liver metastases (CLM) an issue of major importance in current oncology. The area of CLM is subject to great and continuous advances, as its pathophysiologic mechanisms are better understood and more therapeutic and surgical options are developed. Consequently, all professionals involved with the diagnosis, treatment and follow up of CLM should be kept up to date with the latest advances on the field, to provide high standard medical care to their patients. This book is designed to present the state-of-the-art in CLM management and, in doing so, to review the current evidence on CLM, discussing all important topics in the field. Coverage is broad and comprehensive, encompassing introductory topics (history, definitions, epidemiology, etc.), basic science subjects (molecular biology, genetics, dissemination process, etc.) and practical clinical topics (tumor behavior, diagnosis, drug therapy, radiation therapy, surgery, ablation, multidisciplinary teams, etc.). Although comprehensive on the coverage and selection of topics, each chapter is concise and objective, dissecting topics in a practical and direct format. Evidences and recommendations are included. Chapters display a brief introduction of the common knowledge, go straight to the detailed revision of the most recent years of the literature, and end with practical closing observations. This book is a tool for professionals (general and cancer surgeons, HPB surgeons, clinical oncologists, gastroenterologists and medical residents) and interns who search for a qualified and reader friendly revision on topics concerning Colorectal Cancer Liver Metastases. |
| ablation therapy for lung cancer: Current Surgical Therapy E-Book John L. Cameron, Andrew M. Cameron, 2013-11-20 Minimize the risks and maximize your surgical success with Current Surgical Therapy! Hundreds of preeminent general surgeons present you with today’s best treatment and management advice for a number of diseases and associated surgeries, discussing which approach to take, how to avoid or minimize complications, and what outcomes to expect. Current Surgical Therapy is indispensable for quick, efficient review prior to surgery, as well as when preparing for surgical boards and ABSITEs! Find the answers you need quickly inside the user-friendly book. Obtain dependable advice on patient selection, contraindications, techniques, pitfalls, and more from this best-selling surgical resource, trusted by generations of surgeons for decades as the definitive source on the most current surgical approaches. |
| ablation therapy for lung cancer: Tumor Ablation Eric van Sonnenberg, William McMullen, Luigi Solbiati, 2008-09-08 There is an enormous sense of excitement in the communities of cancer research and cancer care as we move into the middle third of the ?rst decade of the 21st century. For the ?rst time,there is a true sense of c- ?dence that the tools provided by the human genome project will enable cancer researchers to crack the code of genomic abnormalities that allow tumor cells to live within the body and provide highly speci?c, virtually non-toxic therapies for the eradication,or at least ?rm control of human cancers. There is also good reason to hope that these same lines of inquiry will yield better tests for screening, early detection, and prev- tion of progression beyond curability. While these developments provide a legitimate basis for much op- mism, many patients will continue to develop cancers and suffer from their debilitating effects, even as research moves ahead. For these in- viduals, it is imperative that the cancer ?eld make the best possible use of the tools available to provide present day cancer patients with the best chances for cure, effective palliation, or, at the very least, relief from symptoms caused by acute intercurrent complications of cancer. A modality that has emerged as a very useful approach to at least some of these goals is tumor ablation by the use of physical or physiochemical approaches. |
| ablation therapy for lung cancer: Thermal Ablation Therapy Amira S. Ashour, Yanhui Guo, Waleed S. Mohamed, 2021-05-21 Thermal Ablation Therapy: Theory and Simulation includes detailed theoretical and technical concepts of thermal ablation therapy in different body organs. Concepts of ablation technology based on different thermal ablation methods are introduced, along with changes in the tissues' mechanical properties due to thermal denaturation. The book emphasizes the mathematical and engineering concepts of RF and MW energy propagation through tissues and where high heating rates produced by MW systems can overcome the heat-sink effects from nearby vessels. The design and tuning of the MW antennas to deliver energy efficiently to specific organ systems such as the liver or lung is also covered. Other sections cover the computational modeling of radiofrequency ablation and microwave ablation procedures for developing and implementing new efficient ablation in clinical systems, numerical simulations for different scenarios of different organs with different size using RF and MW ablation systems with different antennas'/probes design and configurations, and numerical techniques for temperature profile in tissues. Presents the latest mathematical models of microwave and RF ablation theories Discusses the biological responses and engineering principles by which thermal ablation techniques can provide temperature-elevation within the organs of the human body, including action mechanisms, required equipment, needle characteristics and treatment techniques Highlights the different techniques of thermal ablation, including radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation, nanotechnology, and the different metrics used to evaluate the performance of the used antenna within the ablation needle |
| ablation therapy for lung cancer: Endobronchial Ultrasonography Noriaki Kurimoto, David I. K. Fielding, Ali I. Musani, 2011-07-05 Endobronchial ultrasonography (EBUS) is an exciting new diagnostic tool that has added significantly to the diagnosis and staging of lung cancer and other thoracic diseases. This book is co-authored by one of the technology's pioneers and will help the reader to use EBUS to diagnose and stage lung cancer and a variety of different tumours of the chest region. Endobronchial Ultrasonography covers all of the standard techniques and the new developments involved in EBUS as it combines two common procedures, bronchoscopy and real-time ultrasonography. This allows physicians to obtain precise biopsies of lymph nodes and masses within the chest cavity. Over 250 high quality colour digital images are featured throughout the book to illustrate the different applications of EBUS, complemented by specific case studies. This book is accompanied by a companion website featuring over 30 video clips cited in the text. |
| ablation therapy for lung cancer: Laser-induced Interstitial Thermotherapy Gerhard J. Müller, André Roggan, 1995 |
| ablation therapy for lung cancer: Adjuvant Therapy for Breast Cancer Monica Castiglione, Martine J. Piccart, 2009-07-11 Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable. |
| ablation therapy for lung cancer: Image-Guided Interventions in Oncology Christos Georgiades, Hyun S. Kim, 2020-07-28 This book provides an up-to-date and comprehensive primer on image-guided interventions for cancer. Image-guided interventional oncology is gaining popularity as it is a minimally invasive and more precisely targeted approach that both proves more effective and results in fewer side effects. This book’s aim is to provide a clinical guide to interventional oncology for the entire oncology team. Chapters are approached with the same interdisciplinary perspective that is used in the care itself, with each chapter written by an interventional radiologist with contributions from medical, surgical and/or radiation oncologists. Chapters cover the major cancers that can benefit from interventional oncology treatment (including lung, liver, kidney, and bone), as well as some of the physics and physiology behind these interventional modalities. This is an ideal guide for interventional radiologists, medical oncologists, surgical oncologists, radiation oncologists, as well as relevant trainees. |
| ablation therapy for lung cancer: Cryoablation of Cardiac Arrhythmias E-Book Audrius Bredikis, David Wilber, 2011-05-17 Cryoablation of Cardiac Arrhythmias, by Audrius Bredikis, MD and David Wilber, MD, is the first comprehensive text devoted solely to the effective and appropriate use of cryoablation in the management of cardiac arrhythmias. This user-friendly, all-in-one reference provides clear explanations complemented by abundant, high-quality, full-color clinical photos, and at-a-glance tables making it easy to access the information you need to master even the most challenging cryoablation procedures for adult patients, pediatric/adolescent patients, and cardiac surgery patients. Deepen your understanding of all aspects of cryoablation in cardiac arrhythmias while building your clinical knowledge of the latest technologies and procedures. Master the latest cryoablation procedures for adult patients (AVNRT cryoablation, WPW and septal pathways, atrial flutter, atrial fibrillation, balloon-based cryoablation, RVOT cryoablation); pediatric and adolescent patients (AVNRT cryoablation, WPW cryoablation, cryoablation for pediatric coronary sinus); and cardiac surgery patients (left atrial cryoablation procedure for AF; epicardial cryoablation of AF in patients undergoing mitral valve surgery; epicardial ablation with argon-based cryo-clamp; cryoablation of ventricular tachycardias). Implement truly diverse perspectives and worldwide best practices from a team of contributors and editors comprised of the world’s leading experts. Find information quickly and easily thanks to consistent and tightly focused chapters and a full-color design with tables, illustrations, and high-quality images. |
| ablation therapy for lung cancer: Local ablative therapies for the management of lung cancer Xin Ye, Yuliang Li, Roberto Iezzi, 2023-03-24 |
| ablation therapy for lung cancer: Multi-Treatment Modalities of Liver Tumours Nagy A. Habib, 2002 Cancer is one of the major health problems of our time and liver cancer is responsible for over one million deaths per year world-wide, making it the fourth most common cause of death from cancer. Surgical resection of the tumour(s) is the treatment of choice and offers the only chance of prolonged survival. Yet the best attempts are often frustrated by either advanced or co-existent disease that renders the patient non-resectable. This book tackles the many options available to doctors and patients in an attempt to combat this disease. |
| ablation therapy for lung cancer: Modern Thoracic Oncology (In 3 Volumes) Robert Brian Cameron, Diana Lin Gage, Olga Olevsky, 2018-03-19 Modern Thoracic Oncology is the first comprehensive publication on thoracic oncology. Contributors who are world experts have authored concise, relevant and current topics in this field. Whether one desires information regarding lung cancer screening, esophageal cancer staging, mutational analysis, targeted therapies, stereotactic ablative radiation with real-time imaging, minimally-invasive and robotic surgery, combination immunotherapy, microwave/cryoablation, or methods of early cancer detection, this set of three volumes, encompass all of the latest information in the field of thoracic oncology. A rapidly advancing knowledgebase has led to dramatic improvements in individualized or 'personalized' care of patients. However, the myriad of rapid changes has also made it more challenging for thoracic oncologists to comprehend and incorporate these improvements into their daily practice. This staggering and rapid change requires a comprehensive thoracic oncology publication designed to keep clinicians, including pulmonologists, pathologists, radiologists, surgeons, medical oncologists, radiation oncologists and gastroenterologists, well-informed and up-to-date. To meet such needs and to ensure that all areas of thoracic oncology are covered indepth, Modern Thoracic Oncology is published in three volumes.Volume 1 entitled General Principles of Thoracic Oncology provides a comprehensive introduction to thoracic oncology. Principles of thoracic oncology care are discussed in detail and include topics such as thoracic anatomy and embryology, medical evaluation of cancer patients, appropriate imaging modalities with a specific discussion of lung cancer screening, and the basic principles underlying the various treatment modalities. Volume 2 entitled Trachea, Lung, and Pleura addresses lung cancer, one of the most common and deadliest malignancies in the world, as well as two relatively rare respiratory tumors. Volume 3 entitled Esophagus, Mediastinum, Chest Wall and Diaphragm covers esophageal cancer, one of the most rapidly growing malignancies in the world and which still poses significant challenges to thoracic oncologists. Esophageal squamous cell tumors are discussed by experts from Asia where this disease is endemic and adenocarcinoma of the esophagus is detailed by oncologists in the West who face this challenge on a daily basis. |
| ablation therapy for lung cancer: AJCC Cancer Staging Manual Frederick L, Greene, David L. Page, Irvin D. Fleming, April G. Fritz, Charles M. Balch, Daniel G. Haller, Monica Morrow, 2013-11-21 The American Joint Committee on Cancer's Cancer Staging Manual is used by physicians throughout the world to diagnose cancer and determine the extent to which cancer has progressed. All of the TNM staging information included in this Sixth Edition is uniform between the AJCC (American Joint Committee on Cancer) and the UICC (International Union Against Cancer). In addition to the information found in the Handbook, the Manual provides standardized data forms for each anatomic site, which can be utilized as permanent patient records, enabling clinicians and cancer research scientists to maintain consistency in evaluating the efficacy of diagnosis and treatment. The CD-ROM packaged with each Manual contains printable copies of each of the book’s 45 Staging Forms. |
| ablation therapy for lung cancer: Targeted Therapies in Breast Cancer Gw Sledge, George W. Sledge (Jr.), 2012-06 This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management. |
| ablation therapy for lung cancer: Bone Tumour Management Richard Coombs, Gary E. Friedlaender, 1987 |
| ablation therapy for lung cancer: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Practical Approach S.E. Monaco, W.E. Khalbuss, L. Pantanowitz, 2014-05-22 This high-yield reference book focuses on the clinical, technical, and pathological aspects of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Its reviews cover all aspects of EBUS-TBNA, including the clinical perspective, technical aspects of the procedure, and cytomorphology of common and uncommon entities, as well as highlights diagnostic challenges. Each chapter features a multitude of full-color high-resolution images and includes key references to the current literature in the field. Additionally, reference tables and informative figures highlight the salient points. The book is unique in that it is written by experienced thoracic surgeons, pulmonary medicine physicians, and cytopathologists who use EBUS-TBNA in a large medical center. This publication is of interest to individuals learning and practicing cytopathology, in addition to clinicians practicing pulmonary/thoracic medicine or surgery. In short, it provides important pearls of wisdom to create a comprehensive reference for all physicians involved with EBUS-TBNA. |
| ablation therapy for lung cancer: Immunotherapy and multimodality therapy for lung cancer Qun Xue, Jie Mei, Zichao Luo, Wenjun Mao, Yuan Wan, Yifei Liu, 2024-02-07 |
| ablation therapy for lung cancer: Principles and Practice of Interventional Pulmonology Armin Ernst, Felix JF Herth, 2012-12-02 Principles and Practice of Interventional Pulmonology provides a comprehensive text covering all aspects of Interventional Pulmonology. Providing both pathophysiologic background as well as illustrated and clear instruction on how procedures ought to be performed, this text will be of great value to interventional pulmonologists, thoracic surgeons, surgical oncologists, and interventional radiologists. |
| ablation therapy for lung cancer: The Dysautonomia Project Msm Kelly Freeman, MD Phd Goldstein, MD Charles R. Thmpson, 2015-10-05 The Dysautonomia Project is a much needed tool for physicians, patients, or caregivers looking to arm themselves with the power of knowledge. It combines current publications from leaders in the field of autonomic disorders with explanations for doctors and patients about the signs and symptoms, which will aid in reducing the six-year lead time to diagnosis. |
| ablation therapy for lung cancer: Spine Radiosurgery Peter Gerszten, Samuel Ryu, 2015-08-19 Spine Radiosurgery, Second Edition , is a comprehensive text that includes discussions of the latest devices, treatment planning techniques, target definition, and patient selection in this specialty. Written by leading experts in the fields of neurosurgery, radiation oncology, and medical physics, this book is the definitive reference for clinical applications of state-of-the-art radiosurgery of the spine. Key Features: Six new chapters on such topics as histopathological examination of spinal lesions, minimally invasive techniques, and treatment of spinal chordomas More than 100 full-color illustrations demonstrate key concepts Discussion of new treatments for metastatic spine disease and spinal cord compression This book is a must-have resource for clinicians, fellows, and residents in neurosurgery and radiation oncology. Spine surgeons, orthopaedists, medical physicists, and oncologists at all levels will also benefit from the wealth of information provided. |
| ablation therapy for lung cancer: Who Classification of Tumours of the Lung, Pleura, Thymus and Heart International Agency for Research on Cancer, 2015-03-16 WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart is the seventh volume in the Fourth Edition of the WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. |
| ablation therapy for lung cancer: Diagnosis and Treatment of Lung Cancer Frank C. Detterbeck, 2001 Access comprehensive, multidisciplinary guidance on the diagnosis and treatment of lung cancer! This new resource addresses the full range of clinical issues in diagnosis, staging, and treatment, as well as the latest scientific data and evidence-based guidelines. A user-friendlyorganization provides quick reference to data summaries, as well as more comprehensive and detailed information for readers who wish to explore topics in depth. Features contributions by authors from many different disciplines, to ensure a balanced approach. Addresses the clinical issues seen in practice, with the inclusion of basic science research topics that are likely to be put into clinical practice soon. Integrates evidence-based medicine throughout. Assesses the strength of all available dataenabling readers to weigh different arguments and make decisions based on medical issues, values, and the availability and efficacy of interventionsusing a data rating system. Addresses difficult, but clinically relevant issues for which limited data is available. Enables readers to quickly reference findings and data in data summary statements and summary tables. |
| ablation therapy for lung cancer: Thoracic Tumours W. H. O. Classification WHO Classification of Tumours Editorial Board, 2021-04-21 ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Thoracic Tumoursis the fifth available volume in the fifth edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The fifth edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? * Pathologists * Oncologists * Respiratory physicians * Thoracic radiologists * Cancer researchers * Surgeons * Epidemiologists * Cancer registrars This volume: * Prepared by 217 authors and editors * Contributors from around the world * More than 1000 high-quality images * More than 3500 references |
| ablation therapy for lung cancer: Treatment for Non Small Cell Lung Cancer in Distinct Patient Populations Junji Uchino, Torsten Goldmann, Hideharu Kimura, 2022-02-24 |
| ablation therapy for lung cancer: Advances in Radiation Oncology in Lung Cancer Branislav Jeremic, 2011-09-18 This is the second, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings. The first three sections cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including IMRT, IMAT, cyber knife treatment, and tomotherapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer. |
| ablation therapy for lung cancer: Childhood Cancer and Functional Impacts Across the Care Continuum National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Childhood Cancers and Disability, 2021-09-09 Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-specific death rate. Although the improvements in survival are encouraging, they have come at the cost of acute, chronic, and late adverse effects precipitated by the toxicities associated with the individual or combined use of different types of treatment (e.g., surgery, radiation, chemotherapy). In some cases, the impairments resulting from cancer and its treatment are severe enough to qualify a child for U.S. Social Security Administration disability benefits. At the request of Social Security Administration, Childhood Cancer and Functional Impacts Across the Care Continuum provides current information and findings and conclusions regarding the diagnosis, treatment, and prognosis of selected childhood cancers, including different types of malignant solid tumors, and the effect of those cancers on childrenâ (TM)s health and functional capacity, including the relative levels of functional limitation typically associated with the cancers and their treatment. This report also provides a summary of selected treatments currently being studied in clinical trials and identifies any limitations on the availability of these treatments, such as whether treatments are available only in certain geographic areas. |
| ablation therapy for lung cancer: Thermal Ablation Therapy Amira S. Ashour, Yanhui Guo, Waleed S. Mohamed, 2021-05-18 Thermal Ablation Therapy: Theory and Simulation includes detailed theoretical and technical concepts of thermal ablation therapy in different body organs. Concepts of ablation technology based on different thermal ablation methods are introduced, along with changes in the tissues' mechanical properties due to thermal denaturation. The book emphasizes the mathematical and engineering concepts of RF and MW energy propagation through tissues and where high heating rates produced by MW systems can overcome the heat-sink effects from nearby vessels. The design and tuning of the MW antennas to deliver energy efficiently to specific organ systems such as the liver or lung is also covered. Other sections cover the computational modeling of radiofrequency ablation and microwave ablation procedures for developing and implementing new efficient ablation in clinical systems, numerical simulations for different scenarios of different organs with different size using RF and MW ablation systems with different antennas'/probes design and configurations, and numerical techniques for temperature profile in tissues. - Presents the latest mathematical models of microwave and RF ablation theories - Discusses the biological responses and engineering principles by which thermal ablation techniques can provide temperature-elevation within the organs of the human body, including action mechanisms, required equipment, needle characteristics and treatment techniques - Highlights the different techniques of thermal ablation, including radiofrequency ablation, microwave ablation, laser ablation, and ultrasound ablation, nanotechnology, and the different metrics used to evaluate the performance of the used antenna within the ablation needle |
| ablation therapy for lung cancer: Advances in Radiation Oncology in Lung Cancer Branislav Jeremić, 2023-08-14 This is the third, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings in lung cancer and other intrathoracic malignancies. Lung cancer remains the major cancer killer in both sexes worldwide. It is so despite significant progress in recent decades in both diagnostic and treatment approaches. New biological and technological advances in this field are now faster incorporated in the overall decision-making process and are bringing fast and substantial improvements in both survivals and quality of life of lung cancer patients. Optimized patient-oriented approaches are reality of the third decade of this millennium and thoracic oncologists strive towards nothing but seamlessly delivering it in a continuous battle with lung cancer. The first three sections of the work cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer as well as other intrathoracic malignancies are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including stereotactic radiotherapy, and particle therapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer. This concise yet comprehensive book is an invaluable resource for radiation oncologists. |
Cardiac ablation - Mayo Clinic
Feb 2, 2024 · Cardiac ablation is a treatment for irregular heartbeats, called arrhythmias. It uses heat or cold energy to create tiny scars in the heart. The scars block faulty heart signals and …
Ablation: Purpose, Preparation, Risks, and Results - Health
Feb 13, 2024 · An ablation is a minimally invasive surgical procedure that involves using extreme heat, cold, or lasers to create scar tissue or remove unwanted growths. This procedure can …
Cardiac (Heart) Ablation: Procedure Details & Recovery
Nov 7, 2024 · Cardiac ablation (catheter ablation) is a minimally invasive procedure that creates scars to stop the electrical impulses that cause irregular heart rhythms. Healthcare providers …
What Is Cardiac Ablation? - WebMD
Oct 3, 2024 · Know the benefits & risks of cardiac ablation which creates small scars in the heart tissue to stop unusual electrical signals to control arrhythmia.
Ablation for Arrhythmias - American Heart Association
Oct 24, 2024 · Catheter ablation is a procedure that uses radiofrequency energy (similar to microwave heat) to destroy a small area of heart tissue that is causing rapid and irregular …
What Is the Ablation Procedure? - MedicineNet
An ablation procedure is a minimally invasive procedure. It is used to destroy layers of abnormal tissues in various parts of the body using lasers or cold. Ablation can be done for cosmetic …
Why Pulsed Field Ablation for Afib Is the New Go-To Treatment
5 days ago · “Pulsed field ablation uses an electric field to create holes in the cells that causes elimination of those signal cells,” explains Marcin Kowalski, M.D., the director of …
Cardiac ablation procedures : MedlinePlus Medical Encyclopedia
Jul 14, 2024 · Cardiac ablation is a procedure that is used to scar small areas in your heart that may be involved in your heart rhythm problems. This can prevent the abnormal electrical …
Understanding the Heart Ablation Procedure and Recovery
Oct 24, 2024 · Heart ablation involves burning defective heart tissue to improve electrical signaling. Learn who qualifies and more about the surgical techniques here.
Cardiac Ablation | Why It's Done, Risks, What to Expect
Nov 11, 2020 · Cardiac ablation, also known as catheter ablation, is heart procedure to correct arrhythmias, such as atrial fibrillation. Learn about catheter ablation for atrial fibrillation and …
Microwave ablation for subpleural stage I non-small cell lung …
May 6, 2025 · Lung cancer has become a major global public health issue and a research priority. In 2022, China reported 1,060,600 new lung cancer cases and 733,300 lung cancer-related …
Philips Lung suite
lung biopsy and ablation lab Advanced lung biopsy lab As you embark upon the journey to improve the care of your lung cancer patients, it is reassuring to know you can draw upon …
Bronchiolitis Obliterans Organizing Pneumonia after …
Percutaneous radiofrequency (RF) ablation has become popular as a therapy for primary and metastatic lung cancer. An international survey (1) has reported that the mortality rate …
Cryosurgical Ablation of Miscellaneous Solid Tumors other …
Cryosurgical ablation may be considered medically necessary to treat lung cancer when one of the following criteria is met: · The patient has early-stage non-small-cell lung cancer and is a …
Survival benefit of thermal ablation therapy for patients with …
Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis Wei-Yu Yang1,2,YuHe1,2, Qikang Hu1,2, Muyun …
Systematic Review of Image-Guided Thermal Ablation for …
%PDF-1.7 %âãÏÓ 1229 0 obj > endobj xref 1229 122 0000000016 00000 n 0000004301 00000 n 0000004606 00000 n 0000004736 00000 n 0000005239 00000 n 0000005520 00000 n …
Policy Irreversible Electroporation of Tumors Located in the …
Pancreas, Kidney, or Lung Original Policy Date: January 1, 2025 Effective Date: January 1, 2025 ... Clinical Context and Therapy Purpose The American Cancer Society estimates that there …
Cryoablation of Tumors Located in the Kidney, Lung, Breast
Aug 23, 2022 · B. Cryosurgical ablation may be considered medically necessary to treat lung cancer when either of the following criteria is met: 1. The individual has early-stage non-small …
Multidisciplinary Treatment of Early-Stage Non-Small Cell …
Non-Small Cell Lung Cancer PRINCIPLES OF SURGICAL THERAPY Evaluation: • Determination of resectability, surgical staging, and pulmonary resection should be performed by thoracic …
Robotic-assisted bronchoscopy—advancing lung cancer …
transbronchial thermal ablation therapy, have transformed the management of multifocal lung malignancies (11). Although ... for managing lung cancer, from diagnosing different pathologies …
Microwave ablation enhances the systemic immune response …
Jan 18, 2024 · Microwave ablation (MWA) is a key alternative therapy to conventional surgery for the treatment of lung cancer. In addition to eliminating local tumors, MWA may promote …
Focal Tumour Ablation 4: Early-stage Primary Lung Cancer …
Focal Tumour Ablation 4: Early-stage Primary Lung Cancer and Lung Metastases J. Kachura, F. Baldassarre, S. Athreya, M. Midia, R. Malthaner, and the Interventional ... Evidence Summary …
Information for Patients Undergoing Radiofrequency …
Radiofrequency ablation is used to treat early-stage lung cancer. Radiofrequency ablation is a viable and effective treatment option if you:- wish to avoid conventional surgery. ... radiation …
Image-guided combined ablation and resection in thoracic …
Mar 13, 2021 · are now comparable between wedge resection and ablation with 5-year survivals reported at 36 %to 68 and 35 to 56%, respectively, for pulmonary metastases from colo-rectal …
Image-guided percutaneous ablation for lung malignancies
Nov 10, 2022 · Lung ablation treatment can be used as an alternative treatment for patients with inoperable lung cancer in stages I to II to improve disease-free survival and as an adjuvant …
CRYOABLATION FOR CANCER TREATMENT - Ministry of Health
Local ablative therapy including cryoablation and radiofrequency ablation have been started recently in 2014 in the Malaysia National Cancer Institute (Institut Kanser Negara, IKN) for …
Subject: Cryoablation of Tumors Located in the Kidney, Lung, …
lung cancer, pancreatic cancer, renal cell carcinoma, and bone cancer. The purpose of cryosurgical ... 32994 Ablation therapy for reduction or eradication of 1 or more pulmonary …
Treatment of Medically Inoperable Non–small-cell Lung …
NSCLC = non–small-cell lung cancer, PET = positron emission tomography, RF = radiofrequency, RTOG = Radiation Therapy Oncology Group, SBRT = stereotactic body radiation therapy Lung …
Efficacy and safety of thermal ablation of lung
addition, the lung is also the second‑most common site of metastasis.[1] Surgical resection is universally accepted as the first‑line therapy in an early‑stage non‑small cell lung cancer ...
Thyroid Cancer Therapies March 2017 - Department of …
Lung metastases: 150-200 mCi Bone metastases: 175-220 mCi, with possible higher dose, but requires patient specific release calculations. Ordering Procedures: Referring clinician will …
Original Article Clinical outcomes of radioactive seed …
Abstract: This study assessed the efficacy and safety of radioactive iodine-125 seed ablation brachytherapy (RS-ABT) in comparison to microwave ablation therapy (MWAT) for treating …
Radiofrequency ablation of primary non-small cell lung …
Primary non-small cell lung cancer (NSCLC) located in the left lower lobe. The 1-month computed tomogra- phy (CT) scan showed a large area of cavitation, and the size of the ablated lesion in …
Using Pulsed Radiofrequency Ablation to Treat Pain …
Pain associated with cancer is often difficult to treat, even more so when tumors involve peripheral nerves. Therapy is complex and often requires a multimodal approach that can include …
Ablation of Stage I–II Non–Small Cell Lung Cancer in Patients …
Nov 15, 2023 · who develop stage I–II non–small cell lung cancer (NSCLC) are severely limited, given that surgical resection, radiation, and systemic therapy are associated with significant …
Application No. 1403 – Lung Microwave Tissue Ablation
tissue ablation (MTA) for the treatment of primary and secondary lung cancer was received by the Department of Health from N. Stenning & Co. Pty Ltd. ... ablation (RFA) therapy and act as an …
Thermal Ablation of Lung Tumors - Abdominal Image …
Lung cancer remains the leading cause of cancer death in the United States, accountingforanestimated29%ofcancerdeathsin2009.1Pneumonectomyorlobec-tomy with hilar …
Sublobar resection compared with stereotactic body radiation …
Lung cancer is the leading cause of cancer mortality. The estimated number of new cases of lung cancer that will be diagnosed in the United States in 2019 is 228,150, and the estimated …
Original Article Effect of CT-guided microwave ablation for …
The latest incidence of lung cancer in the popu - lation is 16.7%, among which non-small cell lung cancer (NSCLC) is the most common [5, 6]. At present, surgical resection of lesions is still the …
Expert Consensus Document on Pulmonary Metastasectomy
8. Thermal ablation or stereotactic ablative body radiotherapy (SABR) is reasonable therapy for pa-tients with pulmonary oligometastases, particularly for patients considered high risk for …
Stereotactic Radiation for Lung Cancer: A Practical Approach …
Apr 24, 2021 · STATE OF THE ART: CONCISE REVIEW Stereotactic Radiation for Lung Cancer: A Practical Approach to Challenging Scenarios Neal Andruska, MD, PhD,a Hayley B. Stowe, …
ORIGINAL ARTICLE Localized RNA interference therapy to …
therapy strategy to treat residual lung cancer after incomplete MWA. Introduction Primary lung cancer is a leading cause of cancer-related death worldwide. Every year, 1.8 million people are …
Imaging Follow-Up of Nonsurgical Therapies for Lung …
Mar 27, 2023 · Follow-Up of Nonsurgical Therapies for Lung Cancer Cardiothoracic Imaging Murphy DJ, Mayoral M, Larici AR, et al. Keywords ablation, imaging follow-up, lung cancer, …
Society of Interventional Radiology Quality Improvement …
Percutaneous Ablation of Non–Small Cell Lung Cancer and Metastatic Disease to the Lungs Scott J. Genshaft, MD, Robert D. Suh, MD, Fereidoun Abtin, MD, ... ablation is a safe and effective …
6.01.68 Irreversible Electroporation of Tumors Located in the …
The National Comprehensive Cancer Network (NCCN) guidelines for Non -Small Cell Lung Cancer (v8.2024) 68. do not refer to irreversible electroporation. With respect to ablation …
Medicare Coverage of Cancer Treatment Services
Part B covers many medically-necessary cancer-related outpatient services and . treatments, but for some services, you must meet certain conditions You may be in a hospital and still be …
Microwave ablation treatment for medically inoperable stage …
MWA Microwave ablation NSCLC Non-small cell lung cancer OS Overall survival PET–CT Positron emission tomography–computedtomography RFA Radiofrequency ablation SBRT …
454 Oncologic Applications of Photodynamic Therapy - Blue …
• Treatment of early-stage non-small cell lung cancer in individuals who are ineligible for surgery and ... flexible, transoral; with ablation of tumor(s), polyp(s), or other lesion(s) ... For individuals …
Radiofrequency ablation of primary non-small cell lung …
Key words: radiofrequency ablation, non-small cell lung cancer, local progression-free survival, overall survival, ret-rospective study Introduction Lung cancer (LC) is the most common cancer …
Microwave Ablation of Refractory Oligometastatic Non-Small …
MWA = microwave ablation, NSCLC = non–small cell lung cancer, OS = overall survival, PET = positron emission tomography, PFS = progression-free survival, RF = radiofrequency, VIC = …
Microwave Tumor Ablation - AAPC
This technique may also be referred to as microwave coagulation therapy. Background Microwave ablation (MWA) is a technique in which the use of microwave energy induces an ultra-high ...
Concomitant electromagnetic navigation transbronchial …
Objectives: Transbronchial microwave ablation of lung nodules using electromag-netic navigation bronchoscopy is an emerging local therapy for lung oligometasta-ses and multifocal lung …
Cryoablation and immune synergistic effect for lung cancer
we reviewed the literature on cryoablation for lung cancer, as well as the research progress of cryoablation combined with immunotherapy. KEYWORDS cyroablation, immunotharapy, …
Cancer (NSCLC)- VIGOR Study With Systemic Therapy in Early …
Neoadjuvant Soft Tissue Ablation Utilizing Aliya™ Pulsed Electric Fields With Systemic Therapy in Early-stage Resectable Non-small Cell Lung Cancer (NSCLC)- VIGOR Study J. …
Non-surgical Therapies for Early-stage Non-small Cell Lung …
stage Non-small Cell Lung Cancer . Recommended citation: Sultan S, Ullman K, Ester E, et al. Non-surgical Therapies for Early-stage Non- ... Evidence Map of Publications Reporting …
Radiofrequency Ablation for Stage I Non-Small Cell Lung …
and feasible for the treatment of unresectable stage I lung cancer [1–13]. Despite lung RFA being performed for almost 10 years, the literature on the efficacy and long-term outcome for stage I …
Treatment of Pulmonary Colorectal Metastases by …
Conclusion: Radiofrequency ablation of lung metastases is an effective minimally invasive, parenchymal-sparing technique that has very good local control rates ... patients with lung …
Thermal ablation (RFA or Microwave) are used to treat certain …
cancer. Once the needle is in place the electrical current of radiofrequency waves or microwave is applied. You may need to have more than one ablation depending on the size of your cancer. …
Gastrointestinal Side Effects of Treatment for Non-Small Cell …
attack, and kill cancer cells. TARGETED THERAPY – may be used to treat NSCLC by blocking the action of certain genes, proteins, or molecules that cause cancer to grow and spread. …
Stereotactic Ablative Body Radiation Therapy (SABR): A …
Radiation Therapy (SABR): A Resource Version 6.1 Endorsed by The Faculty of Clinical Oncology of The Royal College of Radiologists. Version 6.1, January 2019 ii This document is intended to …
Thermal Ablation for Tumor Treatment |Cryotherapy, RFA, …
Oct 31, 2024 · Thermal ablation is a minimally invasive, image-guided treatment that uses heat or extreme cold to destroy tumor cells, including cancer. Doctors sometimes use ablation to treat …
